-
1
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
Branch, D.W.4
Brey, R.L.5
Cervera, R.6
-
2
-
-
84858754201
-
Manifestations dermatologiques du syndrome des antiphospholipides
-
Frances C, Barete S, Soria A. Manifestations dermatologiques du syndrome des antiphospholipides. Rev Med Interne 2011 []. http://dx.doi.org/10.1016/j.revmed.2011.10.003.
-
(2011)
Rev Med Interne.
-
-
Frances, C.1
Barete, S.2
Soria, A.3
-
3
-
-
20744443648
-
Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases
-
Frances C., Niang S., Laffitte E., Pelletier F., Costedoat N., Piette J.C. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005, 52:1785-1793.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 1785-1793
-
-
Frances, C.1
Niang, S.2
Laffitte, E.3
Pelletier, F.4
Costedoat, N.5
Piette, J.C.6
-
4
-
-
81955163000
-
Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies
-
Reiner P., Galanaud D., Leroux G., Vidailhet M., Haroche J., Huong du L.T., et al. Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies. Mov Disord 2011, 26:2422-2427.
-
(2011)
Mov Disord
, vol.26
, pp. 2422-2427
-
-
Reiner, P.1
Galanaud, D.2
Leroux, G.3
Vidailhet, M.4
Haroche, J.5
Huong du, L.T.6
-
5
-
-
0034924140
-
International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium
-
Wilson W.A., Gharavi A.E., Piette J.C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 2001, 10:457-460.
-
(2001)
Lupus
, vol.10
, pp. 457-460
-
-
Wilson, W.A.1
Gharavi, A.E.2
Piette, J.C.3
-
6
-
-
78049530037
-
Antiphospholipid syndrome
-
Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
-
(2010)
Lancet
, vol.376
, pp. 1498-1509
-
-
Ruiz-Irastorza, G.1
Crowther, M.2
Branch, W.3
Khamashta, M.A.4
-
7
-
-
4043055247
-
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome
-
Tektonidou M.G., Sotsiou F., Nakopoulou L., Vlachoyiannopoulos P.G., Moutsopoulos H.M. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004, 50:2569-2579.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2569-2579
-
-
Tektonidou, M.G.1
Sotsiou, F.2
Nakopoulou, L.3
Vlachoyiannopoulos, P.G.4
Moutsopoulos, H.M.5
-
9
-
-
84858750617
-
Anticorps antiphospholipides et hémostase
-
Masliah-Planchon J, Darnige L. Anticorps antiphospholipides et hémostase. Rev Med Interne 2011 []. http://dx.doi.org/10.1016/j.revmed.2011.10.008.
-
(2011)
Rev Med Interne.
-
-
Masliah-Planchon, J.1
Darnige, L.2
-
10
-
-
79953305113
-
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies
-
Ruiz-Irastorza G., Cuadrado M.J., Ruiz-Arruza I., Brey R., Crowther M., Derksen R., et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 2011, 20:206-218.
-
(2011)
Lupus
, vol.20
, pp. 206-218
-
-
Ruiz-Irastorza, G.1
Cuadrado, M.J.2
Ruiz-Arruza, I.3
Brey, R.4
Crowther, M.5
Derksen, R.6
-
11
-
-
74749086117
-
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
-
Pengo V., Ruffatti A., Legnani C., Gresele P., Barcellona D., Erba N., et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010, 8:237-242.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 237-242
-
-
Pengo, V.1
Ruffatti, A.2
Legnani, C.3
Gresele, P.4
Barcellona, D.5
Erba, N.6
-
12
-
-
79960408773
-
Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies
-
Zuily S., Regnault V., Selton-Suty C., Eschwege V., Bruntz J.F., Bode-Dotto E., et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 2011, 124:215-224.
-
(2011)
Circulation
, vol.124
, pp. 215-224
-
-
Zuily, S.1
Regnault, V.2
Selton-Suty, C.3
Eschwege, V.4
Bruntz, J.F.5
Bode-Dotto, E.6
-
13
-
-
70449390005
-
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
-
de Laat B., Pengo V., Pabinger I., Musial J., Voskuyl A.E., Bultink I.E., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009, 7:1767-1773.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1767-1773
-
-
de Laat, B.1
Pengo, V.2
Pabinger, I.3
Musial, J.4
Voskuyl, A.E.5
Bultink, I.E.6
-
14
-
-
33644865455
-
The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
-
Le Thi Huong D., Wechsler B., Vauthier-Brouzes D., Duhaut P., Costedoat N., Andreu M.R., et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 2006, 45:332-338.
-
(2006)
Rheumatology (Oxford)
, vol.45
, pp. 332-338
-
-
Le Thi Huong, D.1
Wechsler, B.2
Vauthier-Brouzes, D.3
Duhaut, P.4
Costedoat, N.5
Andreu, M.R.6
-
15
-
-
67349205869
-
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the " CAPS Registry"
-
Cervera R., Bucciarelli S., Plasin M.A., Gomez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the " CAPS Registry" J Autoimmun 2009, 32:240-245.
-
(2009)
J Autoimmun
, vol.32
, pp. 240-245
-
-
Cervera, R.1
Bucciarelli, S.2
Plasin, M.A.3
Gomez-Puerta, J.A.4
Plaza, J.5
Pons-Estel, G.6
-
16
-
-
84858710698
-
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'
-
Pengo V., Ruiz-Irastorza G., Denas G., Andreoli L., Khamashta M., Tincani A. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. Autoimmun Rev 2011, [http://dx.doi.org/10.1016/j.bbr.2011.03.031].
-
(2011)
Autoimmun Rev
-
-
Pengo, V.1
Ruiz-Irastorza, G.2
Denas, G.3
Andreoli, L.4
Khamashta, M.5
Tincani, A.6
-
17
-
-
44949233631
-
The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care
-
Snaith A., Pugh L., Simpson C.R., McLay J.S. The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care. Am J Cardiovasc Drugs 2008, 8:207-212.
-
(2008)
Am J Cardiovasc Drugs
, vol.8
, pp. 207-212
-
-
Snaith, A.1
Pugh, L.2
Simpson, C.R.3
McLay, J.S.4
-
18
-
-
84857995541
-
High-risk antimicrobial prescriptions among ambulatory patients on warfarin
-
[Epub ahead of print]
-
Lane M.A., Devine S.T., McDonald J.R. High-risk antimicrobial prescriptions among ambulatory patients on warfarin. J Clin Pharm Ther 2011, [Epub ahead of print]. 10.1111/j.1365-2710.2011.01270.x.
-
(2011)
J Clin Pharm Ther
-
-
Lane, M.A.1
Devine, S.T.2
McDonald, J.R.3
-
19
-
-
0034682048
-
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone
-
Costedoat-Chalumeau N., Amoura Z., Aymard G., Sevin O., Wechsler B., Cacoub P., et al. Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone. Ann Intern Med 2000, 132:631-635.
-
(2000)
Ann Intern Med
, vol.132
, pp. 631-635
-
-
Costedoat-Chalumeau, N.1
Amoura, Z.2
Aymard, G.3
Sevin, O.4
Wechsler, B.5
Cacoub, P.6
-
20
-
-
77951220413
-
Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
-
Cohen H., Machin S.J. Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?. Lupus 2010, 19:486-491.
-
(2010)
Lupus
, vol.19
, pp. 486-491
-
-
Cohen, H.1
Machin, S.J.2
|